These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 69878)

  • 21. Fetal growth achievement and elevated maternal serum alpha-fetoprotein.
    Purdie DW; Young JL; Guthrie KA; Picton CE
    Br J Obstet Gynaecol; 1983 May; 90(5):433-6. PubMed ID: 6189510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of elevated mid-trimester maternal plasma-alpha-fetoprotein values.
    Brock DJ; Barron L; Duncan P; Scrimgeour JB; Watt M
    Lancet; 1979 Jun; 1(8129):1281-2. PubMed ID: 87736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Raised maternal serum alpha-fetoprotein levels and low birth weight babies.
    Smith ML
    Br J Obstet Gynaecol; 1980 Dec; 87(12):1099-102. PubMed ID: 6159917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome in infants born to mothers with unexplained elevations of maternal serum alpha-fetoprotein.
    Burton BK; Dillard RG
    Pediatrics; 1986 Apr; 77(4):582-6. PubMed ID: 2421232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome.
    Smith GC; Wood AM; Pell JP; White IR; Crossley JA; Dobbie R
    N Engl J Med; 2004 Sep; 351(10):978-86. PubMed ID: 15342806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death.
    Waller DK; Lustig LS; Cunningham GC; Golbus MS; Hook EB
    N Engl J Med; 1991 Jul; 325(1):6-10. PubMed ID: 1710779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated levels of midtrimester maternal serum alpha-fetoprotein are associated with preterm delivery but not with fetal growth retardation.
    Davis RO; Goldenberg RL; Boots L; Hoffman HJ; Copper R; Cutter GR; DuBard MB; Cliver SP; Smith RK
    Am J Obstet Gynecol; 1992 Sep; 167(3):596-601. PubMed ID: 1382388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
    Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unexplained elevated maternal serum alpha-fetoprotein levels and pregnancy outcome in twins.
    Hong S; Berkowitz G; Wang W; Stone J; Ainbender E
    Obstet Gynecol; 1996 Sep; 88(3):337-42. PubMed ID: 8752235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
    Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
    Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between serum beta 1-glycoprotein and alpha-fetoprotein levels in the second trimester and birth weight.
    Haddow JE; Knight GJ; Pulkkinen AJ; Smith DE
    Am J Obstet Gynecol; 1984 Jan; 148(1):108-9. PubMed ID: 6197882
    [No Abstract]   [Full Text] [Related]  

  • 32. Is unexplained elevated maternal serum alpha-fetoprotein still important predictor for adverse pregnancy outcome?
    Başbuğ D; Başbuğ A; Gülerman C
    Ginekol Pol; 2017; 88(6):325-330. PubMed ID: 28727133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
    Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
    J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal wastage as a result of an alpha-fetoprotein screening programme.
    Gordon YB; Grudzinskas JG; Kitau MJ; Usherwood MM; Letchworth AT; Chard T
    Lancet; 1978 Apr; 1(8066):677-8. PubMed ID: 76221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of raised maternal serum alpha-fetoprotein in singleton pregnancies with normally formed fetuses.
    Hamilton MP; Abdalla HI; Whitfield CR
    Obstet Gynecol; 1985 Apr; 65(4):465-70. PubMed ID: 2580253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disturbed zinc metabolism and reduced birthweight related to raised maternal serum alpha-fetoprotein in normal human pregnancies.
    Bloxam DL; Williams NR; Waskett RJ; Stewart SG
    Acta Obstet Gynecol Scand; 1994 Nov; 73(10):758-64. PubMed ID: 7529457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal serum alpha-fetoprotein and low birth weight in relation to gestational age.
    Wald NJ; Cuckle HS; Boreham J; Stirrat GM; Turnbull AC
    Br J Obstet Gynaecol; 1982 Mar; 89(3):216-7. PubMed ID: 6175338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects on fetal development of high alpha-fetoprotein and maternal smoking.
    Heinonen S; Ryynänen M; Kirkinen P
    Am J Public Health; 1999 Apr; 89(4):561-3. PubMed ID: 10191802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal serum placental alkaline phosphatase as a marker for low birth weight: results of a pilot study.
    Best RG; Meyer RE; Shipley CF
    South Med J; 1991 Jun; 84(6):740-2. PubMed ID: 1711241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does smoking influence serum alpha-fetoprotein levels in mid-trimester pregnancies?
    Haddow JE; Palomaki G; Kloza EM; Knight GJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1188-91. PubMed ID: 6083799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.